Burow Kristina
SEC CIK 1569248 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | Dir | 114.7K | — | $324.6K | 8 | 2023-12-21 | 2026-07-01 |
| NMRA | Neumora Therapeutics, Inc. | Dir, 10% | 6.05M | $36.43M | — | 13 | 2023-09-19 | 2025-10-27 |
| BOLD | Boundless Bio, Inc. | Dir, 10% | 617.1K | $3.20M | — | 2 | 2024-04-02 | 2024-04-02 |
| SANA | Sana Biotechnology, Inc. | 10% | 10.67M | $10.00M | — | 1 | 2024-02-08 | 2024-02-08 |
| ERAS | Erasca, Inc. | 10% | 5.53M | — | — | 1 | 2021-07-20 | 2021-07-20 |
| BEAM | Beam Therapeutics Inc. | Dir | 2.92M | — | — | 2 | 2021-06-30 | 2021-06-30 |
Most active insiders at SRRK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AKKARAJU SRINIVAS | Dir | $19.99M | — |
| 2 | Qatanani Mo | CSO | — | $8.60M |
| 3 | Hallal David | CEO, Dir | — | $3.97M |
| 4 | Vaishnaw Akshay | Pres of R, D, Dir | — | $1.48M |
| 5 | Sinha Vikas | CFO | — | $1.23M |
| 6 | Woods Keith | COO | — | $1.22M |
| 7 | Ho Junlin | GC | — | $802.3K |
| 8 | Parlavecchio Caryn | CHRO | — | $714.0K |
| 9 | Marantz Jing L. | Chief Medical Off | — | $451.3K |
| 10 | Peng Katie | Dir | — | $337.8K |
| 13 | Burow Kristina | Dir | — | $164.1K |
Transactions 27
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-07-06 16:30 | 2026-07-01 | SRRK | Scholar Rock Holding Corp | Burow Kristina | Dir | S - Sale | $53.74 | -3,053 | 114.7K | -3% | -$164.1K |
| D | 2026-06-08 16:52 | 2026-06-04 | SRRK | Scholar Rock Holding Corp | Burow Kristina | Dir | A - Grant | $0.00 | +6,839 | 117.7K | +6% | $0 |
| DM | 2026-04-24 16:05 | 2026-04-23 | SRRK | Scholar Rock Holding Corp | Burow Kristina | Dir | M - OptEx | $9.14 | +89.8K | 110.9K | +426% | +$820.3K |
| I | 2025-10-29 | 2025-10-27 | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | P - Purchase | $2.61 | +1.92M | 6.05M | +46% | +$5.00M |
| M | 2025-05-30 | 2025-05-29 | SRRK | Scholar Rock Holding Corp | Burow Kristina | Dir | S - Sale | $29.72 | -5,400 | 21.1K | -20% | -$160.5K |
| D | 2025-05-23 | 2025-05-22 | SRRK | Scholar Rock Holding Corp | Burow Kristina | Dir | A - Grant | $0.00 | +7,632 | 26.5K | +41% | $0 |
| D | 2024-07-01 | 2024-06-27 | SRRK | Scholar Rock Holding Corp | Burow Kristina | Dir | A - Grant | $0.00 | +13.5K | 18.8K | +253% | $0 |
| D | 2024-06-14 | 2024-06-13 | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | A - Grant | $0.00 | +20.1K | 47.7K | +73% | $0 |
| DMI | 2024-04-04 | 2024-04-02 | BOLD | Boundless Bio, Inc. | Burow Kristina | Dir, 10% | C - Cnv Deriv | — | +2.43M | 617.1K | New | — |
| DMI | 2024-04-04 | 2024-04-02 | BOLD | Boundless Bio, Inc. | Burow Kristina | Dir, 10% | P - Purchase | $16.00 | +200.0K | 1.18M | +20% | +$3.20M |
| MI | 2024-02-12 | 2024-02-08 | SANA | Sana Biotechnology, Inc. | Burow Kristina | 10% | P - Purchase | $5.50 | +1.82M | 10.67M | +21% | +$10.00M |
| I | 2023-12-26 | 2023-12-21 | SRRK | Scholar Rock Holding Corp | Burow Kristina | Dir | J - Other | $0.00 | -291.9K | 2.35M | -11% | $0 |
| 2023-12-26 | 2023-12-21 | SRRK | Scholar Rock Holding Corp | Burow Kristina | Dir | J - Other | $0.00 | +5,339 | 5,339 | New | $0 | |
| MI | 2023-12-12 | 2023-12-08 | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | J - Other | — | +1.88M | 4.13M | +83% | — |
| 2023-12-12 | 2023-12-08 | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | J - Other | — | +14.0K | 27.6K | +103% | — | |
| MI | 2023-11-15 | 2023-11-13+ | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | P - Purchase | $11.77 | +35.0K | 4.13M | +0.9% | +$412.1K |
| MI | 2023-11-13 | 2023-11-08+ | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | P - Purchase | $10.98 | +140.6K | 4.02M | +4% | +$1.54M |
| MI | 2023-11-07 | 2023-11-03+ | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | P - Purchase | $11.49 | +95.7K | 3.93M | +2% | +$1.10M |
| MI | 2023-09-29 | 2023-09-28+ | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | P - Purchase | $13.68 | +76.5K | 3.80M | +2% | +$1.05M |
| MI | 2023-09-27 | 2023-09-26+ | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | P - Purchase | $11.97 | +58.5K | 3.76M | +2% | +$700.5K |
| MI | 2023-09-25 | 2023-09-22+ | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | P - Purchase | $11.19 | +100.7K | 3.72M | +3% | +$1.13M |
| D | 2023-09-20 | 2023-09-19 | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | C - Cnv Deriv | — | +13.6K | 13.6K | New | — |
| DMI | 2023-09-20 | 2023-09-19 | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | C - Cnv Deriv | — | +17.42M | 2.12M | New | — |
| DI | 2023-09-20 | 2023-09-19 | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Dir, 10% | P - Purchase | $17.00 | +1.50M | 3.62M | +71% | +$25.50M |
| DMI | 2021-07-20 | 2021-07-20 | ERAS | Erasca, Inc. | Burow Kristina | 10% | C - Cnv Deriv | — | +11.06M | 5.53M | New | — |
| MI | 2021-07-02 | 2021-06-30 | BEAM | Beam Therapeutics Inc. | Burow Kristina | Dir | J - Other | $0.00 | -400.0K | 2.92M | -12% | $0 |
| 2021-07-02 | 2021-06-30 | BEAM | Beam Therapeutics Inc. | Burow Kristina | Dir | J - Other | $0.00 | +2,011 | 12.1K | +20% | $0 |
Purchase Sale Sale after option exercise All abbreviations